| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A zinc transporter, transmembrane protein 163, is critical for the biogenesis of platelet dense granules
|
Yuan, Yefeng
|
|
|
137 |
13 |
p. 1804-1817
|
artikel
|
| 2 |
Conditional expression of HGAL leads to the development of diffuse large B-cell lymphoma in mice
|
Raboso-Gallego, Javier
|
|
|
137 |
13 |
p. 1741-1753
|
artikel
|
| 3 |
Cryptic insertion of KMT2A, a rare t(9;11) variant
|
Assaf, Nada
|
|
|
137 |
13 |
p. 1843
|
artikel
|
| 4 |
Double trouble for Langerhans cell histiocytosis
|
Hermiston, Michelle L.
|
|
|
137 |
13 |
p. 1705-1706
|
artikel
|
| 5 |
Editorial Board
|
|
|
|
137 |
13 |
p. i
|
artikel
|
| 6 |
Increased incidence of germline PIEZO1 mutations in individuals with idiopathic erythrocytosis
|
Filser, Mathilde
|
|
|
137 |
13 |
p. 1828-1832
|
artikel
|
| 7 |
Ivosidenib or enasidenib combined with intensive chemotherapy in patients with newly diagnosed AML: a phase 1 study
|
Stein, Eytan M.
|
|
|
137 |
13 |
p. 1792-1803
|
artikel
|
| 8 |
Long-term neurodevelopmental outcomes of hematopoietic stem cell transplantation for late-infantile Krabbe disease
|
Yoon, Isabel C.
|
|
|
137 |
13 |
p. 1719-1730
|
artikel
|
| 9 |
Morschhauser F, Feugier P, Flinn IW, et al. A phase 2 study of venetoclax plus R-CHOP as first-line treatment of patients with diffuse large B-cell lymphoma. Blood. 2021;137(5):600-609.
|
|
|
|
137 |
13 |
p. 1844
|
artikel
|
| 10 |
Mutational landscape of gray zone lymphoma
|
Sarkozy, Clémentine
|
|
|
137 |
13 |
p. 1765-1776
|
artikel
|
| 11 |
Outcomes of patients with large B-cell lymphoma progressing after axicabtagene ciloleucel therapy
|
Spiegel, Jay Y.
|
|
|
137 |
13 |
p. 1832-1835
|
artikel
|
| 12 |
Overcoming T-cell exhaustion in LCH: PD-1 blockade and targeted MAPK inhibition are synergistic in a mouse model of LCH
|
Sengal, Amel
|
|
|
137 |
13 |
p. 1777-1791
|
artikel
|
| 13 |
Platelet life without TMEM163: no dense granules
|
Mammadova-Bach, Elmina
|
|
|
137 |
13 |
p. 1708-1709
|
artikel
|
| 14 |
Procoagulant activities of skeletal muscle and cardiac myosins require both myosin protein and myosin-associated anionic phospholipids
|
Morla, Shravan
|
|
|
137 |
13 |
p. 1839-1842
|
artikel
|
| 15 |
Prophylaxis in hemophilia: how much is enough?
|
Kempton, Christine L.
|
|
|
137 |
13 |
p. 1709-1711
|
artikel
|
| 16 |
Real-world experience with caplacizumab in the management of acute TTP
|
Dutt, Tina
|
|
|
137 |
13 |
p. 1731-1740
|
artikel
|
| 17 |
Rurioctocog alfa pegol PK-guided prophylaxis in hemophilia A: results from the phase 3 PROPEL study
|
Klamroth, Robert
|
|
|
137 |
13 |
p. 1818-1827
|
artikel
|
| 18 |
SSBP2-CSF1R is a recurrent fusion in B-lineage acute lymphoblastic leukemia with diverse genetic presentation and variable outcome
|
Schwab, Claire
|
|
|
137 |
13 |
p. 1835-1838
|
artikel
|
| 19 |
Syndecan-1 and stromal heparan sulfate proteoglycans: key moderators of plasma cell biology and myeloma pathogenesis
|
Ren, Zemin
|
|
|
137 |
13 |
p. 1713-1718
|
artikel
|
| 20 |
Taking aim at IDH in fitter patients with AML
|
Wei, Andrew H.
|
|
|
137 |
13 |
p. 1706-1707
|
artikel
|
| 21 |
Taking gray zone lymphomas out of the shadows
|
Campo, Elías
|
|
|
137 |
13 |
p. 1703-1704
|
artikel
|
| 22 |
Targeting the GCK pathway: a novel and selective therapeutic strategy against RAS-mutated multiple myeloma
|
Li, Shirong
|
|
|
137 |
13 |
p. 1754-1764
|
artikel
|
Tijdschrift beschrijving